<!DOCTYPE HTML SYSTEM "HTML4.DTD" >
<HTML>
<HEAD>
<TITLE>ICD-10: Block T36-T50
</TITLE>
<LINK HREF="style.css" REL="stylesheet" TYPE="text/css">
<META NAME="AUTHOR" CONTENT="Michael Schopen">
<META NAME="DESCRIPTION" CONTENT="International Statistical Classification of Diseases and Related Health Problems (ICD-10). HTML files for WWW.">
<META NAME="KEYWORDS" CONTENT="ICD-10; tabular list;chapter XIX">
<META NAME="COPYRIGHT" CONTENT="WHO">
<META NAME="ROBOTS" CONTENT="index, follow">
<SCRIPT TYPE="text/JavaScript">
  function openSub(URL) {
    var SUB = window.open(URL, "SUB", "dependent=1,height=200,width=500,resizable=1,scrollbars=1") ;
    SUB.focus() ;
  }
</SCRIPT>
<SCRIPT TYPE="text/JavaScript">
function setNavi(url,hash) {
  if (window.name != "SUB") {
    if ((parent.location.href == self.location.href) || (!parent.correct_frame)) {
      window.location.replace('fr-icd.htm?'+url+'+'+hash) ;
    }
    else {
      with (parent.navi.document) {
        open('text/html','replace') ;
        writeln('<HEAD>') ;
        writeln('<TITLE>Navigational frame work ICD-10</TITLE>') ;
        writeln('<link href="style.css" rel="stylesheet" type="text/css">') ;
        writeln('</HEAD>') ;
        writeln('<BODY BGCOLOR="#000080">') ;
        writeln('<table border="0" cellpadding="4" cellspacing="4" width="100%">') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="navi.htm#ka00">List&nbsp;of&nbsp;Chapters</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="ks00.htm">Chapter&nbsp;Introduction</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="ks00.htm#glied">List&nbsp;of&nbsp;Blocks</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="gt33.htm">Previous&nbsp;Block</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="gt51.htm">Next&nbsp;Block</A></td></tr>') ;
        writeln('<tr><td>&nbsp;</td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="_top" HREF="http://www.who.int/classifications/icd">ICD Homepage</A></td></tr></table>') ;
        close() ;
      }
    }
  }
}
</SCRIPT>

</HEAD>

<BODY BGCOLOR="#FFFFFF" onLoad="setNavi('gt36.htm',window.location.hash.substring(1))">

<H1>Chapter XIX
<BR>
<HR>Injury, poisoning and certain other consequences of external causes
<BR>(S00-T98)
</H1>
<H2>Poisoning by drugs, medicaments and biological substances
<BR>(T36-T50)
</H2>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="8">overdose of these substances
<BR>wrong substance given or taken in error
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="8">abuse of non-dependence-producing substances 
<NOBR>(
<A HREF="gf50.htm#f55">F55
</A>)
</NOBR>
<BR>adverse effects ["hypersensitivity", "reaction", etc.] of correct substance properly administered; such cases are to be classified according to the nature of the adverse effect, such as:
<BR>&middot; aspirin gastritis 
<NOBR>(
<A HREF="gk20.htm#k29">K29.-
</A>)
</NOBR>
<BR>&middot; blood disorders 
<NOBR>(
<A HREF="gd50.htm#d50">D50-D76
</A>)
</NOBR>
<BR>&middot; dermatitis:
<BR>&nbsp;&nbsp;&middot; contact 
<NOBR>(
<A HREF="gl20.htm#l23">L23-L25
</A>)
</NOBR>
<BR>&nbsp;&nbsp;&middot; due to substances taken internally 
<NOBR>(
<A HREF="gl20.htm#l27">L27.-
</A>)
</NOBR>
<BR>&middot; nephropathy 
<NOBR>(
<A HREF="gn10.htm#n140">N14.0-N14.2
</A>)
</NOBR>
<BR>&middot; unspecified adverse effect of drug 
<NOBR>(
<A HREF="gt80.htm#t887">T88.7
</A>)
</NOBR>
<BR>drug dependence and related mental and behavioural disorders due to psychoactive substance use 
<NOBR>(
<A HREF="gf10.htm#f10">F10-F19
</A>)
</NOBR>
<BR>drug reaction and poisoning affecting the fetus and newborn 
<NOBR>(
<A HREF="gp00.htm#p00">P00-P96
</A>)
</NOBR>
<BR>pathological drug intoxication 
<NOBR>(
<A HREF="gf10.htm#f10">F10-F19
</A>)
</NOBR>
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t36">
</A>T36
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by systemic antibiotics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">antibiotics:
<BR>&middot; antineoplastic 
<NOBR>(
<A HREF="#t451">T45.1
</A>)
</NOBR>
<BR>&middot; locally applied NEC 
<NOBR>(
<A HREF="#t490">T49.0
</A>)
</NOBR>
<BR>&middot; topically used for:
<BR>&nbsp;&nbsp;&middot; ear, nose and throat 
<NOBR>(
<A HREF="#t496">T49.6
</A>)
</NOBR>
<BR>&nbsp;&nbsp;&middot; eye 
<NOBR>(
<A HREF="#t495">T49.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t360">
</A>T36.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Penicillins
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t361">
</A>T36.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cefalosporins and other beta-lactam antibiotics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t362">
</A>T36.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Chloramphenicol group
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t363">
</A>T36.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Macrolides
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t364">
</A>T36.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Tetracyclines
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t365">
</A>T36.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Aminoglycosides
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Streptomycin
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t366">
</A>T36.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Rifamycins
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t367">
</A>T36.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antifungal antibiotics, systemically used
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t368">
</A>T36.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other systemic antibiotics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t369">
</A>T36.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Systemic antibiotic, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t37">
</A>T37
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by other systemic anti-infectives and antiparasitics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">anti-infectives:
<BR>&middot; locally applied NEC 
<NOBR>(
<A HREF="#t490">T49.0
</A>)
</NOBR>
<BR>&middot; topically used (for):
<BR>&nbsp;&nbsp;&middot; ear, nose and throat 
<NOBR>(
<A HREF="#t496">T49.6
</A>)
</NOBR>
<BR>&nbsp;&nbsp;&middot; eye 
<NOBR>(
<A HREF="#t495">T49.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t370">
</A>T37.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Sulfonamides
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t371">
</A>T37.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antimycobacterial drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">rifamycins 
<NOBR>(
<A HREF="#t366">T36.6
</A>)
</NOBR>
<BR>streptomycin 
<NOBR>(
<A HREF="#t365">T36.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t372">
</A>T37.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antimalarials and drugs acting on other blood protozoa
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">hydroxyquinoline derivatives 
<NOBR>(
<A HREF="#t378">T37.8
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t373">
</A>T37.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other antiprotozoal drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t374">
</A>T37.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Anthelminthics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t375">
</A>T37.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antiviral drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">amantadine 
<NOBR>(
<A HREF="#t428">T42.8
</A>)
</NOBR>
<BR>cytarabine 
<NOBR>(
<A HREF="#t451">T45.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t378">
</A>T37.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified systemic anti-infectives and antiparasitics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hydroxyquinoline derivatives
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">antimalarial drugs 
<NOBR>(
<A HREF="#t372">T37.2
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t379">
</A>T37.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Systemic anti-infective and antiparasitic, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t38">
</A>T38
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">mineralocorticoids and their antagonists 
<NOBR>(
<A HREF="#t500">T50.0
</A>)
</NOBR>
<BR>oxytocic hormones 
<NOBR>(
<A HREF="#t480">T48.0
</A>)
</NOBR>
<BR>parathyroid hormones and derivatives 
<NOBR>(
<A HREF="#t509">T50.9
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t380">
</A>T38.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Glucocorticoids and synthetic analogues
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">glucocorticoids, topically used 
<NOBR>(
<A HREF="#t49">T49.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t381">
</A>T38.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Thyroid hormones and substitutes
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t382">
</A>T38.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antithyroid drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t383">
</A>T38.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Insulin and oral hypoglycaemic [antidiabetic] drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t384">
</A>T38.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Oral contraceptives
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Multiple- and single-ingredient preparations
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t385">
</A>T38.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other estrogens and progestogens
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Mixtures and substitutes
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t386">
</A>T38.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Tamoxifen
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t387">
</A>T38.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Androgens and anabolic congeners
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t388">
</A>T38.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified hormones and their synthetic substitutes
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Anterior pituitary [adenohypophyseal] hormones
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t389">
</A>T38.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified hormone antagonists
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t39">
</A>T39
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by nonopioid analgesics, antipyretics and antirheumatics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t390">
</A>T39.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Salicylates
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t391">
</A>T39.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>4-Aminophenol derivatives
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t392">
</A>T39.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Pyrazolone derivatives
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t393">
</A>T39.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other nonsteroidal anti-inflammatory drugs [NSAID]
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t394">
</A>T39.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antirheumatics, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">glucocorticoids 
<NOBR>(
<A HREF="#t380">T38.0
</A>)
</NOBR>
<BR>salicylates 
<NOBR>(
<A HREF="#t390">T39.0
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t398">
</A>T39.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other nonopioid analgesics and antipyretics, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t399">
</A>T39.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Nonopioid analgesic, antipyretic and antirheumatic, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t40">
</A>T40
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by narcotics and psychodysleptics [hallucinogens]
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">drug dependence and related mental and behavioural disorders due to psychoactive substance use 
<NOBR>(
<A HREF="gf10.htm#f10">F10-F19
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t400">
</A>T40.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Opium
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t401">
</A>T40.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Heroin
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t402">
</A>T40.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other opioids
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Codeine
<BR>Morphine
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t403">
</A>T40.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Methadone
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t404">
</A>T40.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other synthetic narcotics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Pethidine
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t405">
</A>T40.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cocaine
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t406">
</A>T40.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified narcotics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t407">
</A>T40.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cannabis (derivatives)
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t408">
</A>T40.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lysergide [LSD]
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t409">
</A>T40.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified psychodysleptics [hallucinogens]
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Mescaline
<BR>Psilocin
<BR>Psilocybine
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t41">
</A>T41
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by anaesthetics and therapeutic gases
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">benzodiazepines 
<NOBR>(
<A HREF="#t424">T42.4
</A>)
</NOBR>
<BR>cocaine 
<NOBR>(
<A HREF="#t405">T40.5
</A>)
</NOBR>
<BR>opioids 
<NOBR>(
<A HREF="#t400">T40.0-T40.2
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t410">
</A>T41.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Inhaled anaesthetics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">oxygen 
<NOBR>(
<A HREF="#t415">T41.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t411">
</A>T41.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Intravenous anaesthetics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Thiobarbiturates
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t412">
</A>T41.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified general anaesthetics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t413">
</A>T41.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Local anaesthetics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t414">
</A>T41.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Anaesthetic, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t415">
</A>T41.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Therapeutic gases
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Carbon dioxide
<BR>Oxygen
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t42">
</A>T42
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">drug dependence and related mental and behavioural disorders due to psychoactive substance use 
<NOBR>(
<A HREF="gf10.htm#f10">F10-F19
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t420">
</A>T42.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hydantoin derivatives
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t421">
</A>T42.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Iminostilbenes
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Carbamazepine
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t422">
</A>T42.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Succinimides and oxazolidinediones
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t423">
</A>T42.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Barbiturates
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">thiobarbiturates 
<NOBR>(
<A HREF="#t411">T41.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t424">
</A>T42.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Benzodiazepines
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t425">
</A>T42.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mixed antiepileptics, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t426">
</A>T42.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other antiepileptic and sedative-hypnotic drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Methaqualone
<BR>Valproic acid
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">carbamazepine 
<NOBR>(
<A HREF="#t421">T42.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t427">
</A>T42.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antiepileptic and sedative-hypnotic drugs, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Sleeping:
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="MIDDLE" ALIGN="LEFT" COLSPAN="4">&middot; draught
<BR>&middot; drug
<BR>&middot; tablet
<BR>
</TD>
<TD VALIGN="MIDDLE" ALIGN="LEFT" WIDTH="2%">}
<BR>}
<BR>}
<BR>
</TD>
<TD VALIGN="MIDDLE" ALIGN="LEFT" COLSPAN="2">NOS
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t428">
</A>T42.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antiparkinsonism drugs and other central muscle-tone depressants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Amantadine
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t43">
</A>T43
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by psychotropic drugs, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">appetite depressants 
<NOBR>(
<A HREF="#t505">T50.5
</A>)
</NOBR>
<BR>barbiturates 
<NOBR>(
<A HREF="#t423">T42.3
</A>)
</NOBR>
<BR>benzodiazepines 
<NOBR>(
<A HREF="#t424">T42.4
</A>)
</NOBR>
<BR>drug dependence and related mental and behavioural disorders due to psychoactive substance use 
<NOBR>(
<A HREF="gf10.htm#f10">F10-F19
</A>)
</NOBR>
<BR>methaqualone 
<NOBR>(
<A HREF="#t426">T42.6
</A>)
</NOBR>
<BR>psychodysleptics [hallucinogens] 
<NOBR>(
<A HREF="#t407">T40.7-T40.9
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t430">
</A>T43.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Tricyclic and tetracyclic antidepressants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t431">
</A>T43.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Monoamine-oxidase-inhibitor antidepressants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t432">
</A>T43.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified antidepressants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t433">
</A>T43.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Phenothiazine antipsychotics and neuroleptics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t434">
</A>T43.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Butyrophenone and thioxanthene neuroleptics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t435">
</A>T43.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified antipsychotics and neuroleptics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">rauwolfia 
<NOBR>(
<A HREF="#t465">T46.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t436">
</A>T43.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Psychostimulants with abuse potential
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">cocaine 
<NOBR>(
<A HREF="#t405">T40.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t438">
</A>T43.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other psychotropic drugs, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t439">
</A>T43.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Psychotropic drug, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t44">
</A>T44
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by drugs primarily affecting the autonomic nervous system
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t440">
</A>T44.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Anticholinesterase agents
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t441">
</A>T44.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other parasympathomimetics [cholinergics]
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t442">
</A>T44.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Ganglionic blocking drugs, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t443">
</A>T44.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Papaverine
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t444">
</A>T44.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Predominantly alpha-adrenoreceptor agonists, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Metaraminol
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t445">
</A>T44.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Predominantly beta-adrenoreceptor agonists, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">salbutamol 
<NOBR>(
<A HREF="#t486">T48.6
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t446">
</A>T44.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Alpha-adrenoreceptor antagonists, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">ergot alkaloids 
<NOBR>(
<A HREF="#t480">T48.0
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t447">
</A>T44.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Beta-adrenoreceptor antagonists, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t448">
</A>T44.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">clonidine 
<NOBR>(
<A HREF="#t465">T46.5
</A>)
</NOBR>
<BR>guanethidine 
<NOBR>(
<A HREF="#t465">T46.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t449">
</A>T44.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified drugs primarily affecting the autonomic nervous system
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Drug stimulating both alpha- and beta-adrenoreceptors
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t45">
</A>T45
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by primarily systemic and haematological agents, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t450">
</A>T45.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antiallergic and antiemetic drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">phenothiazine-based neuroleptics 
<NOBR>(
<A HREF="#t433">T43.3
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t451">
</A>T45.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antineoplastic and immunosuppressive drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Antineoplastic antibiotics
<BR>Cytarabine
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">tamoxifen 
<NOBR>(
<A HREF="#t386">T38.6
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t452">
</A>T45.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Vitamins, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">nicotinic acid (derivatives) 
<NOBR>(
<A HREF="#t467">T46.7
</A>)
</NOBR>
<BR>vitamin K 
<NOBR>(
<A HREF="#t457">T45.7
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t453">
</A>T45.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Enzymes, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t454">
</A>T45.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Iron and its compounds
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t455">
</A>T45.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Anticoagulants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t456">
</A>T45.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Fibrinolysis-affecting drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t457">
</A>T45.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Anticoagulant antagonists, vitamin K and other coagulants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t458">
</A>T45.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other primarily systemic and haematological agents
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Liver preparations and other antianaemic agents
<BR>Natural blood and blood products
<BR>Plasma substitute
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">immunoglobulin 
<NOBR>(
<A HREF="#t509">T50.9
</A>)
</NOBR>
<BR>iron 
<NOBR>(
<A HREF="#t454">T45.4
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t459">
</A>T45.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Primarily systemic and haematological agent, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t46">
</A>T46
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by agents primarily affecting the cardiovascular system
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">metaraminol 
<NOBR>(
<A HREF="#t444">T44.4
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t460">
</A>T46.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cardiac-stimulant glycosides and drugs of similar action
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t461">
</A>T46.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Calcium-channel blockers
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t462">
</A>T46.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other antidysrhythmic drugs, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">beta-adrenoreceptor antagonists 
<NOBR>(
<A HREF="#t447">T44.7
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t463">
</A>T46.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Coronary vasodilators, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Dipyridamole
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">beta-adrenoreceptor antagonists 
<NOBR>(
<A HREF="#t447">T44.7
</A>)
</NOBR>
<BR>calcium-channel blockers 
<NOBR>(
<A HREF="#t461">T46.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t464">
</A>T46.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Angiotensin-converting-enzyme inhibitors
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t465">
</A>T46.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other antihypertensive drugs, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Clonidine
<BR>Guanethidine
<BR>Rauwolfia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">beta-adrenoreceptor antagonists 
<NOBR>(
<A HREF="#t447">T44.7
</A>)
</NOBR>
<BR>calcium-channel blockers 
<NOBR>(
<A HREF="#t461">T46.1
</A>)
</NOBR>
<BR>diuretics 
<NOBR>(
<A HREF="#t500">T50.0-T50.2
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t466">
</A>T46.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antihyperlipidaemic and antiarteriosclerotic drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t467">
</A>T46.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Peripheral vasodilators
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Nicotinic acid (derivatives)
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">papaverine 
<NOBR>(
<A HREF="#t443">T44.3
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t468">
</A>T46.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antivaricose drugs, including sclerosing agents
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t469">
</A>T46.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified agents primarily affecting the cardiovascular system
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t47">
</A>T47
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by agents primarily affecting the gastrointestinal system
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t470">
</A>T47.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Histamine H
<SUB>2
</SUB>-receptor antagonists
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t471">
</A>T47.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other antacids and anti-gastric-secretion drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t472">
</A>T47.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Stimulant laxatives
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t473">
</A>T47.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Saline and osmotic laxatives
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t474">
</A>T47.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other laxatives
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Intestinal atonia drugs
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t475">
</A>T47.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Digestants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t476">
</A>T47.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antidiarrhoeal drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">systemic antibiotics and other anti-infectives 
<NOBR>(
<A HREF="#t36">T36-T37
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t477">
</A>T47.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Emetics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t478">
</A>T47.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other agents primarily affecting the gastrointestinal system
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t479">
</A>T47.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Agent primarily affecting the gastrointestinal system, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t48">
</A>T48
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t480">
</A>T48.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Oxytocic drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">estrogens, progestogens and antagonists 
<NOBR>(
<A HREF="#t384">T38.4-T38.6
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t481">
</A>T48.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Skeletal muscle relaxants [neuromuscular blocking agents]
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t482">
</A>T48.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified agents primarily acting on muscles
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t483">
</A>T48.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antitussives
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t484">
</A>T48.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Expectorants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t485">
</A>T48.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Anti-common-cold drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t486">
</A>T48.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antiasthmatics, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Salbutamol
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">beta-adrenoreceptor agonists 
<NOBR>(
<A HREF="#t445">T44.5
</A>)
</NOBR>
<BR>anterior pituitary [adenohypophyseal] hormones 
<NOBR>(
<A HREF="#t388">T38.8
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t487">
</A>T48.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified agents primarily acting on the respiratory system
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t49">
</A>T49
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">glucocorticoids, topically used
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t490">
</A>T49.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t491">
</A>T49.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antipruritics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t492">
</A>T49.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Local astringents and local detergents
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t493">
</A>T49.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Emollients, demulcents and protectants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t494">
</A>T49.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Keratolytics, keratoplastics and other hair treatment drugs and preparations
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t495">
</A>T49.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Ophthalmological drugs and preparations
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Eye anti-infectives
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t496">
</A>T49.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Otorhinolaryngological drugs and preparations
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Ear, nose and throat anti-infectives
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t497">
</A>T49.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Dental drugs, topically applied
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t498">
</A>T49.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other topical agents
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Spermicides
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t499">
</A>T49.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Topical agent, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="t50">
</A>T50
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t500">
</A>T50.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mineralocorticoids and their antagonists
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t501">
</A>T50.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Loop [high-ceiling] diuretics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t502">
</A>T50.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Acetazolamide
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t503">
</A>T50.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Electrolytic, caloric and water-balance agents
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Oral rehydration salts
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t504">
</A>T50.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Drugs affecting uric acid metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t505">
</A>T50.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Appetite depressants
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t506">
</A>T50.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Antidotes and chelating agents, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Alcohol deterrents
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t507">
</A>T50.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Analeptics and opioid receptor antagonists
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t508">
</A>T50.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Diagnostic agents
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="t509">
</A>T50.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other and unspecified drugs, medicaments and biological substances
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Acidifying agents
<BR>Alkalizing agents
<BR>Immunoglobulin
<BR>Immunologicals
<BR>Lipotropic drugs
<BR>Parathyroid hormones and derivatives
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<HR>
<TABLE BORDER="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="33%">Processed on 03.06.2003 
<A HREF="mailto:schopen@dimdi.de">M.S.
</A>
</TD>
<TD VALIGN="TOP" ALIGN="CENTER" WIDTH="34%">Source: World Health Organization
</TD>
<TD VALIGN="TOP" ALIGN="RIGHT" WIDTH="33%">&copy; Copyright WHO 1994/2003
</TD>
</TR>
</TABLE>
</BODY >
</HTML>
